◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksC › CME

CME Group Inc (CME) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

FINANCIAL SERVICES · Financial Exchanges & Data · DATA UPDATED 2026-08-23

CME Group Inc (CME) operates in the Financial Exchanges & Data industry and is headquartered in Chicago, United States with about 3,875 employees. Its market capitalization is roughly $99 billion. In the fiscal year ended 2025-12-31, CME reported $6.5B in revenue and $4.0B in net income.

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.

Interactive charts & full statements → Open the CME valuation workbench →

CME Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$6.8B$6.5B$6.1B$5.6B$5.0B$4.7B$4.9B$4.9B$4.3B$3.6B$3.6B$3.3B$3.1B$2.9B$2.9B$3.3B$3.0B$2.6B$2.6B$1.8B$1.1B
Gross Profit$5.5B$5.6B$5.3B$4.8B$4.3B$3.9B$4.0B$4.0B$3.6B$3.1B$3.1B$2.7B$2.5B$2.4B$2.4B$2.8B$2.5B$2.1B$2.1B$1.4B$790M
Gross Margin %81.9%86.1%86.1%85.2%85.0%82.2%82.5%81.5%84.4%84.5%84.9%82.5%81.2%81.1%81.6%84.2%84.3%79.7%80.4%79.7%72.5%
Operating Income (EBIT)$4.4B$4.2B$3.9B$3.4B$3.0B$2.6B$2.6B$2.6B$2.6B$2.3B$2.2B$2.0B$1.8B$1.6B$1.7B$2.0B$1.8B$1.6B$1.6B$1.1B$621M
Operating Margin %65.1%64.9%64.1%61.6%60.1%56.4%54.0%53.2%60.5%63.4%61.2%59.8%56.8%55.8%58.1%61.6%61.0%60.8%61.8%59.8%57.0%
Net Income$4.3B$4.0B$3.5B$3.2B$2.7B$2.6B$2.1B$2.1B$2.0B$4.1B$1.5B$1.2B$1.1B$977M$896M$1.8B$951M$826M$715M$659M$407M
Net Margin %63.1%62.0%57.5%57.8%53.6%56.2%43.1%43.5%45.5%111.5%42.7%37.5%36.2%33.3%30.8%55.2%31.7%31.6%27.9%37.5%37.4%
EBITDA$5.4B$5.7B$5.0B$4.7B$4.0B$3.9B$3.4B$3.3B$3.2B$2.9B$2.6B$2.3B$2.1B$2.0B$2.1B$2.3B$2.1B$1.8B$1.6B$1.2B$696M
Earnings Per Share (EPS)$11.82$11.23$9.80$8.97$7.49$7.35$5.87$5.91$5.71$11.94$4.53$3.69$3.35$2.92$2.70$5.43$2.86$2.48$2.43$2.99$2.32
Shares Outstanding (M)362M360M360M360M359M359M359M358M344M340M339M338M336M334M332M334M332M333M295M221M176M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CME Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$1.7B$1.9B$1.6B$1.5B$1.7B$1.6B$1.5B$1.6B
Gross Profit$1.2B$1.7B$1.4B$1.3B$1.5B$1.4B$1.3B$1.4B
Gross Margin %69.2%88.1%85.4%84.5%86.9%87.4%85.5%86.2%
Operating Income (EBIT)$1.1B$1.3B$1.0B$973M$1.1B$1.1B$947M$1.0B
Operating Margin %64.9%69.7%61.8%63.2%66.7%67.5%62.1%64.6%
Net Income$1.0B$1.2B$1.2B$908M$1.0B$956M$875M$913M
Net Margin %61.1%61.4%70.8%59.1%59.8%58.2%57.3%57.6%
EBITDA$834M$1.6B$1.6B$1.3B$1.5B$1.4B$1.2B$1.3B
Earnings Per Share (EPS)$2.88$3.18$3.24$2.52$2.81$2.65$2.43$2.54
Shares Outstanding (M)362M363M360M360M360M360M360M360M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CME Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$4.3B$4.3B$3.7B$3.5B$3.1B$2.4B$2.7B$2.7B$2.4B$1.8B$1.7B$1.5B$1.3B$1.3B$1.2B$1.3B$1.4B$1.1B$1.2B$814M$472M
Capital Expenditures (CapEx)$96M$84M$94M$76M$90M$127M$198M$246M$117M$82M$92M$114M$141M$126M$142M$172M$160M$158M$200M$164M$88M
Free Cash Flow (FCF)$4.2B$4.2B$3.6B$3.4B$3.0B$2.3B$2.5B$2.4B$2.3B$1.8B$1.6B$1.4B$1.2B$1.2B$1.1B$1.2B$1.2B$925M$997M$651M$384M
FCF Margin %62.2%64.3%58.7%60.5%59.1%48.5%51.6%49.9%53.9%48.2%45.2%42.1%37.0%39.3%36.9%35.8%39.8%35.4%38.9%37.1%35.2%
Dividends Paid$4.1B$3.9B$3.6B$3.2B$2.6B$2.2B$2.1B$1.7B$2.1B$2.0B$1.8B$1.3B$1.5B$599M$1.2B$373M$913M$306M$615M$152M$88M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CME Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$947M$1.3B$1.1B$968M$1.1B$1.1B$1.0B$1.0B
Capital Expenditures (CapEx)$24M$22M$32M$18M$18M$14M$26M$30M
Free Cash Flow (FCF)$924M$1.2B$1.1B$950M$1.0B$1.1B$992M$973M
FCF Margin %54.1%65.8%66.8%61.8%61.5%67.1%65.0%61.4%
Dividends Paid$468M$2.7B$455M$455M$455M$2.6B$419M$418M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CME Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$194.7B$198.5B$137.4B$129.7B$174.2B$196.8B$124.7B$75.2B$77.5B$75.8B$69.4B$67.4B$72.2B$54.3B$38.9B$40.8B$35.0B$35.7B$48.2B$20.3B$4.3B
Cash & Cash Equivalents$2.1B$4.4B$2.9B$2.9B$2.7B$2.8B$1.6B$1.6B$1.4B$1.9B$1.9B$1.7B$1.4B$2.5B$1.6B$1.0B$855M$261M$298M$845M$970M
Total Liabilities$168.2B$169.8B$111.0B$103.0B$147.3B$169.4B$98.3B$49.1B$51.5B$53.4B$49.0B$46.8B$51.3B$33.1B$17.4B$19.1B$14.9B$16.4B$29.5B$8.0B$2.8B
Total Debt (Short + Long-Term)$3.4B$3.5B$3.4B$3.5B$3.4B$3.4B$3.5B$3.8B$4.4B$2.2B$2.2B$2.2B$2.1B$2.9B$2.9B$11.4B$2.5B$2.3B$3.2B$164M$521M
Total Shareholders' Equity$26.5B$28.7B$26.5B$26.7B$26.9B$27.4B$26.4B$26.2B$25.9B$22.4B$20.3B$20.6B$20.9B$21.2B$21.4B$21.6B$20.1B$19.3B$18.7B$12.3B$1.5B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CME viewer.

CME Metric Deep Dives

Other Companies in Financial Exchanges & Data

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← CMDYAll “C” companiesCMER →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.